lx3305
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2009 (NCT00847886)
Timeline
Indications
Studied for
Mechanism of action
- Sphingosine-1-phosphate lyase 1INHIBITOR
SGPL1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- lx3305
- lx3305
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01417052 | Phase 1 | Sep 1, 2011 | Lexicon Pharmaceuticals |
| NCT00903383 | Phase 2 | Jul 1, 2009 | Lexicon Pharmaceuticals |
| NCT00847886 | Phase 1 | Feb 1, 2009 | Lexicon Pharmaceuticals |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lexicon Pharmaceuticals | For profit | 3 | 3 | 2 | 2009 |
1 organizations
Page 1 / 1